Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Needham cut Semtech Corporation (NASDAQ: SMTC) price target from $35 to $26. Needham analyst Quinn Bolton maintained a Buy rating. Semtech shares rose 0.1% to close at $16.70 on Wednesday. See how other analysts view this stock.
- Barclays increased the price target for Toll Brothers, Inc. (NYSE: TOL) from $74 to $95. Barclays analyst Matthew Bouley maintained an Underweight rating. Toll Brothers shares gained 1.9% to close at $88.90 on Wednesday. See how other analysts view this stock.
- Piper Sandler increased the price target for Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) from $33 to $45. Piper Sandler analyst David Amsellem downgraded the stock from Overweight to Neutral. Cerevel Therapeutics shares gained 3.8% to close ...